hit counter

Zuranolone for Depression: Rapid Efficacy & Safety in Clinical Trials (2023 Review)

by

Zuranolone, a novel antidepressant, shows promise in treating depression, as evidenced by a recent meta-analysis. A new study investigated zuranolone’s efficacy and safety, focusing on short-term rapid antidepressant effects. Highlights: Zuranolone Effectiveness: Demonstrated significant improvement in depression severity scores compared to placebo, with notable effects by day 15. Treatment-Emergent Adverse Events (TEAEs): Increased incidence in …

Read more

Black Cumin (Nigella Sativa) Seed Oil Extract (BCO-5) May Improve Non-Restorative Sleep (2023 Study)

by

Sleep is a fundamental aspect of human health, deeply intertwined with our overall well-being. Recent research examined a unique black cumin extract, BCO-5, and found that it may be beneficial in individuals with non-restorative sleep disorders. Highlights: BCO-5, a Unique Black Cumin Extract: BCO-5 is a proprietary extract of Nigella sativa (black cumin) showing promising …

Read more

Electroconvulsive Therapy (ECT) & Long-Term Cognitive Effects in Major Depression (2023 Review)

by

Electroconvulsive therapy (ECT) has long been a controversial yet potent treatment for major depressive disorder (MDD), particularly in cases resistant to conventional therapies. Despite its effectiveness, the long-term cognitive effects of ECT have been a subject of intense debate. A recent meta-analysis offers new insights into these cognitive changes, shedding light on the nuances of …

Read more

Latest Treatments for Frontotemporal Dementia (FTD): High-Dose Oxytocin Emerges as the Standout (2023 Review)

by

Frontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of pharmacological treatments. Highlights: High-Dose Oxytocin Shows Promise: High-dose oxytocin (72 international units) has been linked to significant improvements in neuropsychiatric symptoms and daily interactive activities in FTD patients. Piracetam Poses Risks: Contrarily, …

Read more

Bilateral Anterior Capsulotomy (BAC) for Treatment-Resistant Depression & OCD (2023 Case Reports)

by

In the relentless pursuit of effective treatments for mental disorders, neurosurgery offers a glimmer of hope where traditional methods falter. Bilateral anterior capsulotomy (BAC), a neurosurgical procedure, emerges as an option for patients with treatment-resistant depression (TRD) and obsessive-compulsive disorder (OCD), offering substantial relief with minimal side effects. Highlights: Bilateral Anterior Capsulotomy (BAC) is a …

Read more

tDCS for the Treatment of Cravings in Drug Addiction (2023 Review)

by

Transcranial direct current stimulation (tDCS) emerges as a promising, noninvasive treatment for reducing cravings in substance addiction. This technique involves the use of scalp electrodes to modulate neural activity, influencing cravings associated with drug addiction or substance dependence. Despite its promise, further research is needed to standardize protocols and understand long-term efficacy. Highlights: tDCS significantly …

Read more

SSRI-Induced Sexual Dysfunction Reversed with “Drug Holidays” on Weekends (2024 Study)

by

Selective serotonin reuptake inhibitors (SSRIs) are a mainstay in the treatment of various mental disorders but often come with the unwelcome side effect of sexual dysfunction. This issue can significantly affect patients’ adherence to their medication regime, often leading to treatment discontinuation. A recent clinical trial offers a new perspective, suggesting that ‘drug holidays’ – …

Read more